about Richard Cohen
Richard Cohen regularly represents institutional and high net worth investors in disputes over investment fraud, voting rights, and corporate governance, with an Antitrust Litigation emphasis on hedge funds and closed-end funds. Healthcare Litigation
Healthcare Litigation, Antitrust Litigation
Noteworthy Cases & Achievements:
Richard Cohen has argued and won landmark decisions over the past 20 years for national health insurers and classes of third-party payers that established Testimonials their direct (non-subrogation) rights to recover overcharges from prescription drug manufacturers and the rights of Medicare Advantage Organizations to recover reimbursement from mass tort settlements, producing recoveries of hundreds of millions of dollars for our clients. Mr. Cohen has also successfully won judgments of dismissal of numerous class action lawsuits for health insurers.
Mr. Cohen advises boards of directors of publicly-traded companies and has served as a director for two of them. He is currently a director of Oaktree Strategic Finance Corporation (NASDAQ:OCSI), a closed-end business development company.
Mr. Cohen is a frequent speaker at legal education conferences, concerning the antitrust law, pharmaceutical litigation, managed care disputes, closed-end funds, and investor advocacy. He was a contributor to the American Bar Association’s “State Antitrust Enforcement Handbook.” Mr. Cohen is the president of the Westchester (NY) and Fairfield (CT) region of the American Jewish Committee, serves on AJC’s National Board of Governors, and has participated in AJC diplomatic missions in Germany, Poland, Estonia, and Lithuania.
A.B. Georgetown University (1977)
J.D. New York University School of Law (1980)
New York, Pennsylvania; the U.S. Supreme Court; multiple U.S. Courts of Appeals and federal district courts